The recent identification of activating mutations in the G-alpha protein from the GNAQ gene in uveal melanoma has provided a key insight into potential strategies in which to target uveal melanoma cell growth and survival [3], [4]. This evidence concerns the gene GNAQ and uveal melanoma.